September 8/2015 EuropeWill Europe Ever Achieve Regulatory Convergence? Fifty years after the first European Union drug regulation was adopted, it may seem odd to speak of Europe still edging towards regulation in this field. But, writes Reflector, this is still the case, and France's bid to regain its influence reveals how far Europe is from fully achieving regulatory convergence .../ Read more / |
||||||||
|
| ||||||||
| Europe The “Seasoned” European Biopharma CEO: A Rare Commodity A recent survey of European biopharma companies and board members revealed that 80 percent of firms find access to qualified senior executives to be a challenge, with the toughest spot to fill being the “seasoned CEO”. Simon Bartholomew reports .../ Read more / |
||||||||
| Emerging Markets China's Pharma Industry Resilient in the Face of Slowing Economy The current economic slowdown notwithstanding, a new survey offers a very positive outlook for the pharma industry in China, with 92 percent of respondents believing their China sales will double over the next five years. Cameron Sharp reports .../ Read more / |
||||||||
| Compliance As the U.S. Open Payments system improves operations and resolves discrepancies, the emergence of widely diverse and contradictory transparency programs in Europe and other nations raises new challenges for pharma, writes Jill Wechsler ... / Read more / |
||||||||
| Technology Analysts are saying that more than 4 million Apple Watches were sold in the Q2 2015, grabbing up to 75 percent of the smartwatch market, way ahead of nearest rival Samsung. This continued rise of wearable technology is thanks in particular to health and fitness applications. Peter Houston reports ... / Read more / |
||||||||
| Adherence Biotech Positioning for Boom Times and Beyond Pharm Exec sat down with prominent biotech investment strategist, Tony Gibney, to better gauge today's state of play in this critically innovative segment of the life sciences industry .../ Read more / |
||||||||
industry update
|
 |
 |
 |
 |
 |